Early cystectomy for clinical stage T1 transitional cell carcinoma of the bladder

Seminars in Urologic Oncology

Volumn 15, Issue 3, 1997, Pages 154-160

  Esrig, D ^a   Freeman, J A ^a   Stein, J P ^a   Skinner, D G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cystectomy; Superficial bladder cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE;

BLADDER CARCINOMA; BLADDER RECONSTRUCTION; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CYSTECTOMY; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0030790317     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)